Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge

• Status: Completed
• Trial end date: 2019-06-30
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will receive a prescription for inhaled corticosteroids in addition to standard care, and half of the patients will receive standard card alone.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: New York City Health and Hospitals Corporation
• Treatments: Beclomethasone; Budesonide

Criteria

Inclusion Criteria:

• Chief complaint consistent with asthma exacerbation

• Previous diagnosis of asthma by a physician OR one major in the Asthma Predictive Index (API) with two prior episodes of wheezing in the past year.

• Major criteria in the API: parent with asthma, patient with eczema, evidence of sensitization to allergens in the air

• Received oral corticosteroids as part of treatment during this visit for acute asthma exacerbation.

• Deemed well enough after interventions to be discharged by the treating physician.

• If <5 years of age, possession of nebulizer machine at home.

Exclusion Criteria:

• Received asthma controller medications within four weeks prior to presentation

• Allergy to intervention asthma controller medications.